Journal article

Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis

TJ Martin, NA Sims, KW Ng

OSTEOPOROSIS INTERNATIONAL | SPRINGER LONDON LTD | Published : 2008

Abstract

The understanding of cell interactions and genetic controls of bone cells has provided new approaches to drug development for osteoporosis. Current emphasis in the development of new anabolic therapies is directed at modifying the effects of Wnt signalling on osteoblast differentiation and bone formation. Local signalling that results in bone formation during remodelling takes place in several ways. Growth factors released from resorbed bone matrix can contribute to preosteoblast differentiation and bone formation. Osteoclasts in the bone multicellular units (BMUs) might also generate activity that contributes to bone formation. The preosteoblasts themselves, growing in the resorption space,..

View full abstract